key: cord-0891755-iolnvg35 authors: Vázquez-Temprano, Nuria; Ursúa-Díaz, María Isabel; Salgado-Barreira, Ángel; Vázquez-Gallardo, Rafael; Túñez Bastida, Victoria; Anibarro, Luis title: [Translated article] Decline of Tuberculosis Rates and COVID-19 Pandemic. Fact or Fiction? date: 2022-02-11 journal: Arch Bronconeumol DOI: 10.1016/j.arbres.2021.05.035 sha: 27909fbba81fa2d39c2a906ec0f8870a832524b8 doc_id: 891755 cord_uid: iolnvg35 nan The study did not require Ethics Committee approval as it is a pooled data analysis and there is no possibility of identifying patients. In the second half of 2020, 172 cases of TB were recorded, compared with 262 in the same period of 2019, corresponding to a 6-monthly incidence of 6.4 vs. 9.7 per 100,000 inhabitants (risk reduction = 34.35%; 95% CI: 20.43-45.84). Case data were obtained from active searches in microbiology and other records in 34.3% (59/172) of cases in the second half of 2020 vs. 29.0% (76/262) in 2019 (p = 0.29). The percentage of patients with forms of TB suggestive of greater diagnostic delay (patients with bacilliferous disease or cavitation on chest X-ray) was similar in both periods: 29.1% had bacilliferous disease in the second half of 2020 vs. 28.2% in the second half of 2019 (p = 0.94); whereas the percentage of patients with cavitation on chest X-ray was 14.5% in the second half of 2020 vs. 17.2% in the same period of 2019 (p = 0.55). The median diagnostic delay in the second half of 2020 was 60.5 days (IQR: 23.0-122.0) vs. 65 days (IQR: 30.5-121.5) in the same period of 2019 (p = 0.51). The analysis of 6-monthly trends revealed a 32% annual decrease in risk for the 2015-2020 period (95% CI 22-42%), a rate that is greater than the 20% decrease observed over the 2015-2019 period as a whole (95% CI 7-33%). The segmented Poisson regression analysis shows a break point in incidence after 2020 with a RR value of 0.980 (95% CI 0.967-0.993) for the initial part of the regression line (2015-2019), compared to a steeper decline in 2020 (RR = 0.790; 95% CI 0.635-0.945) (Fig. 1) . A significant decrease was therefore observed in registered cases of TB following the introduction of preventive measures for COVID-19. This could be due to 3, not necessarily exclusive, factors. First, possible under-reporting of cases. Secondly, possible diagnostic delay caused by re-allocation of health resources (microbiology laboratories, primary care, and the TB programs themselves), difficulties in accessing oversaturated healthcare services, and/or reluctance to attend hospitals or health centers for fear of exposure to SARS-CoV-2 13, 14 . Finally, there may be a real decline in TB cases associated with the reduction of respiratory-borne diseases following the introduction of confinement measures, social distancing, and use of masks 15 . We believe that this is the most realistic explanation in our autonomous community. Although some resources allocated to the TB control program in Galicia have been diverted, TB units have retained their basic structure and functions. Immediate care has been maintained for patients, contacts, screened patients, and patients with suspected TB diagnosis, while active contact tracing continues. There was no increase in the number of patients with advanced forms of the disease (bacilliferous, cavitation on X-ray) or in diagnostic delays in the second half of 2020, an observation that supports our hypothesis that the incidence of tuberculosis has actually decreased. Although TB has hitherto been thought to manifest in only 50% of cases in the first 2 years of infection, recent evidence suggests that the incubation period is shorter in most cases 16 . This also supports the hypothesis of a real decline in TB, despite the short time since the start of isolation measures in March 2020. Studies conducted in other countries also describe a decrease in the incidence of TB, although they do not focus so closely on the impact of COVID-19 control measures 17, 18 . The development of the pandemic over time, the measures taken to control it, and the longer-term monitoring of TB incidence rates will definitively confirm the existence of a real decline in the incidence of TB associated with social isolation measures. Be that as it may, we agree with other authors that a possible decline in TB cases is no reason to relax disease control measures, but should rather serve as an incentive to reinforce vigilance 19, 20 . In conclusion, social distancing and respiratory isolation measures, including the widespread use of masks, contribute positively to the decrease in the incidence of TB in our environment. Pulse survey on continuity of essential health services during the Covid-19 pandemic Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses Worldwide effects of coronavirus disease pandemic on tuberculosis services Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries Impact of the COVID-19 pandemic on TB detection and mortality in Global tuberculosis report The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital-acquired infections in a Taiwanese hospital Zero measles after COVID-19 pandemic in Taiwan The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: likely role of lower transmission in the community Epidemiology of tuberculosis in Galicia Spain, 16 years after the launch of the Galician tuberculosis programme Impact of COVID-19 on tuberculosis control Increase in tuberculosis diagnostic delay during first wave of the COVID-19 Pandemic: data from an italian infectious disease referral hospital Facemask use in community settings to prevent respiratory infection transmission: a rapid review and meta-analysis Revisiting the timetable of tuberculosis Tuberculosis -United States Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China The potential impact of COVID-19-related disruption on tuberculosis burden ARBRES-3000 Notes from the field: effects of the COVID-19 response on tuberculosis prevention and control efforts -United States the Galician Tuberculosis Prevention and Control Working Group ♦